ARCHIVES

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

This article is from The Cancer Letter archive.

Vol. 18 No. 27 | July 3, 1992

Download PDF Visit The Full Archive

Related Articles

NIH COI Rule Mandates More Disclosure, Leaves Institutions In Charge Of Ethics Of Extramural Researchers

September 16, 2011

Program Announcements

July 25, 1986

Cancer Groups In Campaign To Draft Pazdur For FDA.

March 2, 2001

Funding Opportunities: PAs Available.

January 28, 2005

In Brief: ACR Moving To D.C.; FDA Advisors OK VP-16 NDA; Wiernik Tells Missouri No; Dewys Moves To DRCCA

October 15, 1982

Y-90 Radioembolization Stabilizes Liver Metastases in 98.5 Percent Of Breast Cancer Patients in Study

March 28, 2014